Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Raphael Medical is an Israeli medical technology company dedicated to the development of advanced robotic solutions for neurorehabilitation. The company specializes in treating patients with severe neurological damage, including those in vegetative or minimally conscious states resulting from traumatic brain injury, stroke, or spinal cord injuries. Their core technology, the Raphael system, is a robotic verticalization device that provides early-stage mobilization and sensory stimulation to promote neurological recovery and prevent the complications of prolonged immobility. By integrating mechanical movement with physiological feedback, Raphael Medical aims to improve patient outcomes in the critical window following acute injury. The company's systems are utilized in specialized rehabilitation facilities globally to bridge the gap between intensive care and active physical therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Raphael Medical.